AIC
CYTK icon

Archer Investment Corporation’s Cytokinetics CYTK Stock Holding History

Archer Investment Corporation’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,040
Closed -$48.9K – 1155
2024
Q4 		$48.9K Hold
1,040
– – 0.01% 447
2024
Q3 		$54.9K Hold
1,040
– – 0.01% 428
2024
Q2 		$56.3K Hold
1,040
– – 0.02% 413
2024
Q1 		$72.9K Sell
1,040
-350
-25% -$27.1K 0.02% 368
2023
Q4 		$116K Hold
1,390
– – 0.04% 283
2023
Q3 		$40.9K Hold
1,390
– – 0.01% 408
2023
Q2 		$45.3K Hold
1,390
– – 0.02% 393
2023
Q1 		$51.2K Buy
+1,390
New +$56.7K 0.02% 384

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Archer Investment Corporation's CYTK Position: Q1 2025 in Review

Archer Investment Corporation sold out of Cytokinetics (CYTK) in Q1 2025, closing a stake of 1,040 shares — an estimated $48.9K sold.

Archer Investment Corporation first reported a position in CYTK in Q1 2023 and held it in 8 quarters. The position peaked at $116K in Q4 2023. 355 funds tracked by Wall St. Rank hold CYTK as of Q1 2025.

  • Archer Investment Corporation reported no remaining Cytokinetics position as of Q1 2025 after selling out during the quarter.
  • Archer Investment Corporation sold 1,040 Cytokinetics shares in Q1 2025, an estimated $48.9K.
  • Archer Investment Corporation first reported a position in Cytokinetics in Q1 2023 and held it in 8 quarters.
  • Archer Investment Corporation's Cytokinetics position peaked at $116K in Q4 2023.
  • 355 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2025.

Based on Archer Investment Corporation's 13F filing for Q1 2025, filed 5 May 2025.